SCHIMMEL PAUL 4
4 · aTYR PHARMA INC · Filed Jul 24, 2024
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
SCHIMMEL PAUL
Director
Transactions
- Purchase
Common Stock
2024-07-23$1.82/sh+6,648$12,075→ 360,723 total(indirect: See Footnote) - Purchase
Common Stock
2024-07-22$1.74/sh+41,052$71,500→ 354,075 total(indirect: See Footnote) - Purchase
Common Stock
2024-07-24$1.93/sh+52,300$101,038→ 413,023 total(indirect: See Footnote)
Holdings
- 679,143(indirect: See Footnote)
Common Stock
- 8,890
Common Stock
Footnotes (5)
- [F1]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.71 to $1.78 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]These shares are owned by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.
- [F3]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.775 to $1.86 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F4]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.88 to $1.96 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F5]These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.